Chemical Analysis Toxic Analysis Chemical Substance Property Information, Catalog of Supplier Manufacturer Distributor And Custom Synthesis Oganic Synthesis Bio-synthesis Companies For Raw Material Laboratory Reagent Equipment Solution Intermediate Specialty Chemicals And So On.

Search   

CAS Properties

MSDS  
: 5-MERCAPTO-2-NITRO-BENZOIC ACID
CAS  :
SYNONYMS  : 5-MERCAPTO-2-NITRO-BENZOIC ACID
MNB

  
MSDS LIST:
  		•  MSDS Benzamide, N-methyl-N-nitroso- CAS 63412-06-6 MSDS * N-Methyl-N-nitrosobenzamide * MNB
    MSDS   : Benzamide, N-methyl-N-nitroso- CAS   : 63412-06-6 SYNONYMS   : * N-Methyl-N-nitrosobenzamide * MNB *** CHEMICAL IDENTIFICATION *** RTECS NUMBER : CV5585350 CHEMICAL NAME : Benzamide, N-methyl-N-nitroso- CAS REGISTRY NUMBER : 63412-06-6 BEILSTEIN REFERENCE NO. : 2254366 REFERENCE : 4-09-00-00943 (Beilstein Handbook Reference) LAST UPDATED : 199612 DATA ITEMS CITED : 4 MOLECULAR FORMULA : C8-H8-N2-O2 MOLECULAR WEIGHT : 164.18 WISWESSER LINE NOTATION : ONN1&VRCOMPOUND DESCRIPTOR : Tumorigen Mutagen SYNONYMS/TRADE NAMES : * N-Methyl-N-nitrosobenzamide * MNB *** HEALTH HAZARD DATA *** ** ACUTE TOXICITY DATA ** TYPE OF TEST : LD50 - Lethal dose, 50 percent kill ROUTE OF EXPOSURE : Intraperitoneal SPECIES OBSERVED : Rodent - rat DOSE/DURATION : 70 mg/kg TOXIC EFFECTS : Details of toxic effects not reported other than lethal dose value REFERENCE : JJIND8 JNCI, Journal of the National Cancer Institute. (Washington, DC) V.61-79, 1978-87. For publisher information, see...
    http://www.chemcas.com/msds/cas/msds18/63412-06-6.asp
  		• MSDS CAS# N/A junsei_ehost_jp_10291jis.asp
    ? 鈥⒚佲?懊庘?毭? s 陇沤脪 脤 脹艗矛 陆 脽 脡鈥欌?︹?攑鈥毬? 茅鈥⒚浥捗?姑? F鈥揾鈥懊? 鈥⒚浥捗? 啪 A沤猫鈥樏溾?毭夆?懊? 娄 鈥姑? C 脛 z艩铆鈥溾劉 冒鈥欌?︹?攑鈥毬? 茅鈥 6, 藴R鈥沤啪鈥毭屸?榌鈥檜 鈥鈥樏屸?毭? 脦 路 茅鈥欌?⑺喢撆解?? 鈧? 鈥揬藴I鈥毬得埪⒚βも?⒙犅封?笴脤脿脝脹艗矛茂鈥欌?︹?攑鈥毬得勨?陇B 鈥⒚浥捗?姑痽鈥毭戔?姑檥沤啪鈥榌鈥檜 鈥鈥歐鈥鈥揬藴I h沤~ 鈥箉鈥毭戔?⒚浥捗?榌鈥檜鈥鈥毭? 篓 炉 茅 A 鈥⒚浥捗?姑?欌?︹?攑 艩脗鈥孤?毭夆?樏? 路 茅鈥欌?⑺喢撆解?? 鈧? mnB鈥⒚┾?毬访壜っβ⒚埪祂鈥癛藴鈥β? 鈥擟艩A鈥⒚? 脦艗 矛 脥鈥? 鹿 鈥? 茫 鈥橝鈥? 鈥犫?橝鈥⒚慌矫扁?? a 藴 藴R鈥鈥⒙ㄢ?毭懊撀絫鈥毭屸?攅艩铆鈥毭夆?脽A沤c鈥斅奥幻溌矫峴 艩藛鈥⒙?箊沤没脺鈥毭壜陈姑劽?鈥楽鈥毭堚?⒚犆壦喢毬稡 7, 沤忙藛碌鈥毬⑩?箉鈥毭戔?⒚浥犆? 茫 脤鈥? 藛脫 沤忙藛碌鈥毬? 鈥枚鈥笴A茠~Xg 鈥 茠KX鈥毬?鈥澝р?犆塆锚陆猫鈥箊鈥溍悸访┞泵喢埪⒚β? rpB鈥⒚┾?毬? 鈥澟犫?⒚団?? 鈥斺?︹?櫭扳?毭?姑捗涒? 猫 陆 碌 C 鈥 矛鈥姑? 锚鈥毭芭犅? C 茅 B 鈥 矛鈥姑嗏?欌?犫?毭嵥喢? H A i鈥芭掆?毭? 碌 脠 垄鈥 B鈥⒚┾?毬? 脫藛 鈥櫭? G 脷 脤 脝 脺 禄鈥癬沤-鈥箌 鈥⒚浥犆? B鈥⒚栤?孤蹬扖 脦鈥皘 B鈥⒚┾?毬? 脟艩脹 脡 脙藛芒鈥斅? 忙 脤 C鈥? 脛 碌 冒 搂鈥搢 B鈥?-鈥毬? 脛 碌 拢鈥斆? 漏 脺 禄鈥癬沤 鈥箌 3/6 鈥⑵捖斥?奥? 艩w 艩鈥澟铰?懊? 8, 鈥揬藴I h沤~鈥箉鈥毭戔?⒚浥捗?榌鈥檜 鈥櫭娾?笴鈥艩路 鈥? 鈥檜鈥毭扳?攑鈥毬? 脛鈥 茠~ X g鈥鈥毭? 卤 猫 枚鈥笴鈥漐鈥渪 冒鈥櫭? - 脹 脗 B 鈥揬藴I艗脌艩E鈥鈥筀 鈥⒙р?檒鈥毭嶁?⒚濃?櫭? 鲁 鈥毭? 脛 脠 垄 鈥⒚濃?澝碘?樏幟? 鈥姑団?⑴犫?漴鈥笴鈥樷?⑩?檜 鈥⒚浥捗?姑? 鈥 鈥揾鈥茠} X N鈥鈥擫鈥笯 K p鈥揾鈥溍吰拀 X N鈥鈥樷?斺?笴 A 鈥姑? C艗脛 z艩铆鈥溾劉鈥 |鈥...
    http://www.chemcas.org/msds_archive/msds_01/cas/gb_msds/junsei_ehost_jp_10291jis.asp
  		• MSDS 64742-95-6 108-65-6 Outcome of SIAM 15
    NUMBER FORMULA 1,3-Benzenedicarboxylic acid, polymer with 156559-10-3 (C12H18N2O2.C8H6O4. hexanedioic acid, 1,6-hexanediol, 3-hydroxy- C6H14O2.C6H10O4.C5 2-(hydroxymethyl)-2-methylpropanoic acid H10O4)x.xC4H11NO and 5-isocyanato-1-(isocyanatomethyl)- 1,3,3-trimethylcyclohexane, compd. with 2- (dimethylamino)ethanol 10-Phenothiazine propionic acid 362-03-8 C15H13NO2S Formaldehyde, polymer with (chloromethyl) 168750-21-8 C8H10O4.x(C7H8O.C3 oxirane and 2-methylphenol, 4-cyclohexene- H5ClO.CH2O)x.x 1,2-dicarboxylate 2-propenoate C3H4O2 L-Proline, 5-oxo-, (1R,2S,5R)-5-methyl-2- 64519-44-4 C15H25NO3 (1-methylethyl)cyclohexyl ester D-Proline, 5-oxo-, (1R,2S,5R)-5-methyl-2- 68127-22-0 C15H25NO3 (1-methylethyl)cyclohexyl ester Proline, 5-oxo-, (1R,2S,5R)-5-methyl-2-(1- 52528-10-6 C15H25NO3 methylethyl)cyclohexyl ester Sodium salt of ((2-hydroxy ethyl) imino) bis 136016-61-0 C4H13NO8P2.4Na (methylene)) bis phosphonic acid, N-oxide Sodium salt of ((tetrahydro-2-hydroxy-4H- 136016-62-0 C4H11NO7P2.3Na...
    http://www.chemcas.org/msds113/supplier/cas/6/64742-95-6_108-65.asp
  		• MSDS 7429-90-5 7440-47-3 7440-48-4 7440-50-8 7439-89-6 7439-96-5 7439-98-7 7440-02-0 7440-03-1 7440-25-7 7440-32-6 7440-33-7 1314-36-9 002-00-7 001-00-9
    -like disease and high blood uric acid. Inhalation of fumes has caused kidney damage, respiratory irritation and liver damage in animals. Skin and eye contact may cause irritation. EH40 - Molybdenum compounds (as Mo): Soluble - OES 5.0 mg/m3 (8 hours TWA), 10 mg/m3 (15 minute reference period) Insoluble - OES 10 mg/m3 (8 hours TWA), 20 mg/m3 (15 minute reference period) 12 Special Metals Corporation Material Safety Data Sheet Nickel (Ni) Exposure Limits(1): TLV: 1.5 mg/m3 as metal (Inhalable Fraction) PEL: 1 mg/m3 for metal and insoluble compounds as Ni CAS No.(2): 7440-02-0 LD50: >9,000 mg/kg, rat, oral The U.S. National Toxicology Program (NTP) 10th Report on Carcinogens has listed "metallic nickel" as "reasonably anticipated to be a human carcinogen" and "nickel compounds" as "known human carcinogens". "Nickel Alloys" were reviewed but not listed. The International Agency for Research on Cancer (IARC) concluded that nickel compounds were carcinogenic to humans and that metallic nickel...
    http://www.chemcas.org/msds114/supplier/cas/979/7429-90-5_7440-47-3_7440-48-4_7440-50-8_7439-89-6_7439-96.asp
    ALL PAGES On Chemical Properties IN THIS GROUP
    NameCASSynonymsMolecular FormulaMolecular Weight
    METHYL-PHE-PRO-AMINO-CYCLOHEXYLGLYCINE METHYL-PHE-PRO-AMINO-CYCLOHEXYLGLYCINE
    MIN
    MIP MIP
    MONOISOPROPYL ESTER PHOSPHONIC ACID GROUP
    ARGATROBAN ARGATROBAN
    MD-805
    MIT
    MITSUBISHI INHIBITOR
    1-HEXADECYL-3-TRIFLUOROETHYL-SN-GLYCERO-2-PHOSPHATE METHANE 1-HEXADECYL-3-TRIFLUOROETHYL-SN-GLYCERO-2-PHOSPHATE METHANE
    MJ33 INHIBITOR
    MJI
    INDINAVIR INDINAVIR
    MK1
    N-[2(R)-HYDROXY-1(S)-INDANYL]-5-[(2(S)-TERTIARY BUTYLAMINOCARBONYL)-4(3-PYRIDYLMETHYL)PIPERAZINO]-4(S)-HYDROXY-2(R)-PHENYLMETHYLPENTANAMIDE
    6-BENZYL-1-ETHOXYMETHYL-5-ISOPROPYL URACIL 6-BENZYL-1-ETHOXYMETHYL-5-ISOPROPYL URACIL
    MKC
    DICARBOXYLIC ACID C3 DICARBOXYLIC ACID C3
    MALONIC ACID
    METAHNEDICARBOXYLIC ACID
    MLA
    PROPANEDIOLIC ACID
    MALONYL-COENZYME A MALONYL-COENZYME A
    MLC
    MLE MLE
    N-METHYLLEUCINE
    MLG MLG
    N-METHYL-N-PROPARGYL-3-(2,4-DICHLOROPHENOXY)PROPYLAMINE
    N-[3-(2,4-DICHLOROPHENOXY)PROPYL]-N-METHYL-N-PROP-2-YNYLAMINE
    MALONATE ION MALONATE ION
    MLI
    METHYLLYCACONITINE METHYLLYCACONITINE
    MLK
    3-AMINO-3-OXOPROPANOIC ACID 3-AMINO-3-OXOPROPANOIC ACID
    MLM
    (S)-2-(PHOSPHONOXY)CAPROYL-L-LEUCYL-P-NITROANILIDE (S)-2-(PHOSPHONOXY)CAPROYL-L-LEUCYL-P-NITROANILIDE
    MLN
    1-AMINOCYCLOPROPYLPHOSPHONATE 1-AMINOCYCLOPROPYLPHOSPHONATE
    MLP
    AMYLOTRIOSE AMYLOTRIOSE
    MALTOTRIOSE
    MLR
    MALATE ION MALATE ION
    MLT
    MLZ MLZ
    N-METHYL-LYSINE
    1,4,8,11-TETRAAZA-CYCLOTETRADECANE CU(II) 1,4,8,11-TETRAAZA-CYCLOTETRADECANE CU(II)
    CU-CYCLAM
    MM1
    1,1'-[1,4-PHENYLENEBIS(METHYLENE)]BIS[1,4,8,11-TETRAAZA-CYCLOTETRADECANE]CU(II)2 1,1'-[1,4-PHENYLENEBIS(METHYLENE)]BIS[1,4,8,11-TETRAAZA-CYCLOTETRADECANE]CU(II)2
    CU-BICYCLAM
    MM2
    MM3 MM3
    N-HYDROXY-4-[(4-METHOXYLPHENYL)SULFONYL]-2,2-DIMETHYL-HEXAHYDRO-1,4-THIAZEPINE-3(S)-CARBOXAMIDE
    MM4 MM4
    MOLYBDENUM (IV) OXIDE
    MMA MMA
    O1-METHYL-MANNOSE
    METHYL MERCURY ION METHYL MERCURY ION
    MMC
    MMI MMI
    MMI-175
    N-[(4S,5S,7R)-8-({(S)-1-[(BENZYLAMINO)OXOMETHYL]-2-METHYLPROPYL}AMINO)-5-HYDROXY-2,7-DIMETHYL-8-OXO-OCT-4-YL]-(4S,7S)-4-ISOPROPYL-2,5,9-TRIOXO-1-OXA-3,6,10-TRIAZACYCLOHEXADECANE-7-CARBOXAMIDE
    5-DEOXY-5-{[(1S)-1-HYDROXYETHYL]AMINO}-D-GLUCITOL 5-DEOXY-5-{[(1S)-1-HYDROXYETHYL]AMINO}-D-GLUCITOL
    MMN
    N-ACETYLMANNOSAMINITOL
    MMO MMO
    N~5~-(DIAMINOMETHYLENE)-N~2~-METHYLORNITHINE
    MMP MMP
    N-METHYLMESOPORPHYRIN
    MERCAPTOMETHYL PHOSPHONATE MERCAPTOMETHYL PHOSPHONATE
    MMQ
    MANGANESE (II) ION MANGANESE (II) ION
    MN
    MN2 MN2
    MANGANESE (III) ION MANGANESE (III) ION
    MN3
    MANGANESE ION, 5 WATERS COORDINATED MANGANESE ION, 5 WATERS COORDINATED
    MN5
    2-O-METHYL-5-N-ACETYL-ALPHA-D- NEURAMINIC ACID 2-O-METHYL-5-N-ACETYL-ALPHA-D- NEURAMINIC ACID
    MNA
    5-MERCAPTO-2-NITRO-BENZOIC ACID 5-MERCAPTO-2-NITRO-BENZOIC ACID
    MNB
    METHYL ISOCYANIDE METHYL ISOCYANIDE
    MNC
    MENOGARIL MENOGARIL
    MNG
    4,N-DIMETHYLNORLEUCINE 4,N-DIMETHYLNORLEUCINE
    MNL
    (3S)-N-METHANESULFONYL-3-({1-[N-(2-NAPHTOYL)-L-VALYL]-L-PROLYL}AMINO)-4-OXOBUTANAMIDE (3S)-N-METHANESULFONYL-3-({1-[N-(2-NAPHTOYL)-L-VALYL]-L-PROLYL}AMINO)-4-OXOBUTANAMIDE
    MNO
    2-(3-NITROPHENYL)ACETIC ACID 2-(3-NITROPHENYL)ACETIC ACID
    MNP
    M-NITROPHENYL AMINOETHYLDIPHOSPHATE BERYLLIUM TRIFLUORIDE M-NITROPHENYL AMINOETHYLDIPHOSPHATE BERYLLIUM TRIFLUORIDE
    MNQ
    5-(DIMETHYLAMINO)-1-NAPHTHALENESULFONAMIDE 5-(DIMETHYLAMINO)-1-NAPHTHALENESULFONAMIDE
    DANSYLAMIDE
    MNS
    2'(3')-O-N-METHYLANTHRANILOYL-ADENOSINE-5'-DIPHOSPHATE 2'(3')-O-N-METHYLANTHRANILOYL-ADENOSINE-5'-DIPHOSPHATE
    MANT-ADP
    MNT
    MNV MNV
    N-METHYL-C-AMINO VALINE
    1,8-DI-HYDROXY-4-NITRO-XANTHEN-9-ONE 1,8-DI-HYDROXY-4-NITRO-XANTHEN-9-ONE
    MNX
    5,8-DI-AMINO-1,4-DIHYDROXY-ANTHRAQUINONE 5,8-DI-AMINO-1,4-DIHYDROXY-ANTHRAQUINONE
    MNY
    MO MO
    MOLYBDENUM ATOM
    MAGNESIUM ION, 1 WATER COORDINATED MAGNESIUM ION, 1 WATER COORDINATED
    MO1
    MAGNESIUM ION, 2 WATERS COORDINATED MAGNESIUM ION, 2 WATERS COORDINATED
    MO2
    MAGNESIUM ION, 3 WATERS COORDINATED MAGNESIUM ION, 3 WATERS COORDINATED
    MO3



    HBCChem,Inc

    Chemical Information Net Copyright Reserved